2006 Annual Meeting | Case Studies in Stroke

Date Thursday 04/06/06

Time 07:00 PM - 10:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Case Studies Program

Director(s) Philip B. Gorelick, MD, MPH, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should be able to better understand the diagnosis and management of unusual causes of stroke, intracranial occlusive disease, vascular cognitive impairment, and the use of statin agents in stroke prevention; the role of new inflammatory markers and tests of inflammation as applied to individual stroke patients or patients at risk of stroke; and the role of heparin in acute management of stroke.

CME Available No CME available

Core Competencies Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident, Nurse

Event Timeline
07:00 PM - 07:20 PM		Inflammation and Stroke: What Is the Lipoprotein-associated Phospholipase A2 (Lp-PLA1) Test All About? Philip B. Gorelick, MD, MPH, FAAN
07:00 PM - 10:00 PM		Refreshments
07:20 PM - 07:40 PM		Vascular Cognitive Impairment (VCI): Should We Be Gently Elevating Blood Pressure or Reducing It to Prevent Cognitive Decline? Philip B. Gorelick, MD, MPH, FAAN
07:40 PM - 08:00 PM		Should Every Stroke Patient Receive a Statin Agent? Philip B. Gorelick, MD, MPH, FAAN
08:00 PM - 08:10 PM		Break
08:10 PM - 08:30 PM		Symptomatic Intracranial Occlusive Disease: Who Gets It and How Should It Be Managed and Prevented? Louis R. Caplan, MD, FAAN
08:30 PM - 08:50 PM		Heparin Therapy in Stroke: Work Horse or Trojan Horse? Louis R. Caplan, MD, FAAN
08:50 PM - 09:00 PM		Break
09:00 PM - 09:30 PM		Unusual Stroke Diagnoses and Fascinomas Louis R. Caplan, MD, FAAN
09:30 PM - 10:00 PM		Audience Presentation of Challenging Cases and Questions

Faculty Disclosures
Philip B. Gorelick, MD, MPH, FAAN	Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AstraZeneca. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AMGEN. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Gorelick has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Thorek Memorial Hospital. Dr. Gorelick has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Thorek Memorial Hospital.
Louis R. Caplan, MD, FAAN	No disclosure on file

��ɫ��

��ɫ��